Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices

Stephanie L Mayne1, Michelle E Ross2, Lihai Song1

  • 1Center for Pediatric Clinical Effectiveness, PolicyLab.

Pediatrics
|June 1, 2016
PubMed

Insights

Pediatric mental health care shows significant practice variation in diagnosis and medication. Psychiatrist availability partially explains these differences, but more research is needed.

Area of Science:

  • Pediatric mental health
  • Health services research
  • Psychopharmacology

Background:

  • Primary care pediatricians manage a growing number of child mental health concerns.
  • Significant gaps exist in understanding practice-level variations in diagnosing and prescribing psychotropic medications for children.

Purpose of the Study:

  • To investigate practice-level variability in mental health diagnosis and psychotropic medication prescribing among children in primary care settings.
  • To explore factors associated with this variability, including the availability of mental health providers and the proportion of children in foster care.

Main Methods:

  • Retrospective analysis of electronic health records from 43 US primary care practices (2009-2014).
  • Inclusion of children aged 4-18 years with at least one office visit.
  • Statistical analysis using logistic regression and generalized linear mixed models to assess variability and associated factors.

Main Results:

  • 15% of nearly 300,000 children received a mental health diagnosis; 14% were prescribed psychotropic medication.
  • Wide practice-level variation observed in diagnosis (e.g., ADHD 1%-16%) and prescribing (any medication 4%-26%; multiple classes 1%-12%).
  • Psychiatrist availability was associated with diagnosis and prescribing, unlike colocation of mental health professionals or foster care rates.

Conclusions:

  • Substantial variation exists in pediatric mental health diagnosis and psychotropic prescribing across primary care practices.
  • Psychiatrist availability partially explains, but does not fully account for, this variability.
  • Further research is crucial to understand the drivers of practice-level differences and their impact on child mental health outcomes.
Abstract

Related Concept Videos

Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368